Skip to main content
. 2016 Mar 3;7(16):22140–22149. doi: 10.18632/oncotarget.7903

Table 1. Association data for the most significant SNPs in the case-control study of all CUP patients shown in Figure 1.

SNP Chr Position Risk allele* MAFctrl OR_het OR_hom P_Geno OR_Allele P_Allele P** I2** Gene Location Distance
rs9347983 6 165386880 G 0.24 1.45 1.85 1.1×10−5 1.40 1.4×10−6 0.46 0.0 RP11-300M24.1 flanking 3′UTR 224kb
rs741828 7 155616377 T 0.25 1.46 2.06 7.2×10−7 1.44 1.1×10−7 0.19 40.0 Y RNA flanking 3′UTR 55Kb
rs2660852 12 94969679 C 0.36 1.33 2.50 7.4×10−7 1.44 1.9×10−7 0.81 0.0 LTA4H flanking 5′UTR 8.2kb
rs4771282 13 97144122 T 0.39 1.56 1.94 7.4×10−7 1.40 1.4×10−7 0.35 3.9 RP11-12OE13.1 flanking 5′UTR 16Kb
rs477145 21 31684281 T 0.31 1.47 1.93 1.2×10−6 1.42 1.1×10−7 0.05 66.9 TIAM1 intron −50673
rs2835931 21 38043518 T 0.24 1.53 1.89 1.8×10−6 1.43 4.0×10−7 0.51 0.0 KCNJ6 intron −34214
*

The risk is calculated to the risk allele

**

Heterogeneity for data from the 3 centers